(Q53440587)

14 May 2018

title

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. (English)

1 reference

14 May 2018

ESMO Guidelines Committee

author

5

object named as

ESMO Guidelines Committee

1 reference

14 May 2018

author name string

D E Peterson

1

1 reference

14 May 2018

C B Boers-Doets

2

1 reference

14 May 2018

R J Bensadoun

3

1 reference

14 May 2018

J Herrstedt

4

1 reference

14 May 2018

publication date

4 July 2015

1 reference

14 May 2018

published in

Annals of Oncology

1 reference

14 May 2018

volume

26 Suppl 5

1 reference

14 May 2018

page(s)

v139-51

1 reference

14 May 2018

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Mammalian target of rapamycin inhibitor-associated stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Oral complications of targeted cancer therapies: a narrative literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Managing stomatitis in patients treated with Mammalian target of rapamycin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Clinical presentation and management of mTOR inhibitor-associated stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Targeted therapy-induced diarrhea: A review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Stool form scale as a useful guide to intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Systematic review of basic oral care for the management of oral mucositis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

EGFR inhibitor-associated acneiform folliculitis: assessment and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Clinical practice. Aphthous ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Oral mucosal injury caused by cancer therapies: current management and new frontiers in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV202

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDV202

1 reference

14 May 2018

PubMed ID

26142468

1 reference

14 May 2018